Cargando…
Preclinical antitumor activity of SST0116CL1: A novel heat shock protein 90 inhibitor
4-Amino substituted resorcino-isoxazole (SST0116CL1) (property of Sigma-Tau Research Switzerland S.A.) is a potent, second generation, small-molecule heat shock protein 90 inhibitor (Hsp90i). SST0116CL1 binds to the ATP binding pocket of Hsp90, and interferes with Hsp90 chaperone function thus resul...
Autores principales: | VESCI, LOREDANA, MILAZZO, FERDINANDO MARIA, CAROLO, VALERIA, PACE, SILVIA, GIANINI, GIUSEPE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151799/ https://www.ncbi.nlm.nih.gov/pubmed/25096516 http://dx.doi.org/10.3892/ijo.2014.2575 |
Ejemplares similares
-
Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor
por: Vesci, Loredana, et al.
Publicado: (2014) -
EHMTI-0116. Tension type primary headaches and fibromyalgia: strong correlations
por: Karapetyan, A, et al.
Publicado: (2014) -
PA01.16.Effect of sheetaprabha tablets on ethylene glycol induced urolithiasis in rats
por: Vemula, Sampath Kumar, et al.
Publicado: (2012) -
OA01.16. Effects of drakshavaleha on weight and crown-rump length in developing mice embryo
por: Kumar, Sunil, et al.
Publicado: (2012) -
Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase
por: Pala, Daniele, et al.
Publicado: (2016)